Mechanism of action of benzodiazepines on GABA A receptors
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Wild-type and mutant alpha1beta2gamma2 GABA(A) receptors were expressed in Xenopus laevis oocytes and examined using the two-electrode voltage clamp. Dose-response relationships for GABA were compared in the absence and presence of 1 microM diazepam (DZP) or methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM). The dose-current relationships yielded EC(50)'s (concentration for half-maximal activation) of 41.0+/-3.0, 21.7+/-2.7, and 118.3+/-6.8 microM for GABA, GABA plus DZP, and GABA plus DMCM, respectively.DZP- and DMCM-mediated modulation were examined in GABA(A) receptors in which the beta-subunit carries the L259S mutation. This mutation has been shown to produce spontaneous opening and impart a leftward shift in the dose-response relationship. In this case, neither DZP nor DMCM produced a significant alteration in the GABA dose-response relationship with GABA EC(50)'s of 0.078+/-0.005, 0.12+/-0.03, and 0.14+/-0.004 microM for GABA, GABA plus 1 microM DZP, and GABA plus 1 microM DMCM.DZP- and DMCM-mediated modulations were examined in GABA(A) receptors in which the alpha-subunit carries the L263S mutation. This mutation also produced spontaneous opening and a leftward shift of the GABA dose-response relation, but to a lesser extent than that of betaL259S. In this case, the leftward and rightward shifts for DZP and DMCM were still present with EC(50)'s=0.24+/-0.03, 0.14+/-0.02, and 1.2+/-0.04 microM for GABA, GABA plus 1 microM DZP, and GABA plus 1 microM DMCM, respectively.Oocytes expressing ultrahigh levels of wild-type GABA(A) receptors exhibited currents in response to 1 muM DZP alone, whereas DMCM decreased the baseline current. The DZP-mediated activation currents were determined in wild-type receptors as well as receptors in which the GABA binding site was mutated (beta2Y205S). The EC(50)'s for DZP-mediated activation were 72.0+/-2.0 and 115+/-6.2 nM, respectively, similar to the EC(50) for DZP-mediated enhancement of the wild-type GABA-activated current (64.8+/-3.7 nM). Our results support a mechanism in which DZP increases the apparent affinity of the receptor, not by altering the affinity of the closed state, but rather by shifting the equilibrium towards the high-affinity open state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BZD binds between the alpha and the gamma subunit. It enhances the effect of GABA at the GABA-A receptor, allowing it to exert a more significant effect [2].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Intrinsic dynamics of an enzyme underlies catalysis
Eisenmesser, E. Z., Millet, O., Labeikovsky, W., Korzhnev, D. M., Wolf-Watz, M., Bosco, D. A., Skalicky, J. J., Kay, L. E., & Kern, D. (2005) · Nature · doi:10.1038/nature04105 · Cited by 1,101
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs
Liman, E. R., Tytgat, J., & Hess, P. (1992) · Neuron · doi:10.1016/0896-6273(92)90239-a · Cited by 1,084
The benzodiazepine binding site of GABAA receptors
Sigel, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01118-8 · Cited by 594
Study, R. E., & Barker, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7180 · Cited by 561
Functional domains of GABAA receptors
Smith, G. B., & Olsen, R. W. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89009-4 · Cited by 489
Stoichiometry and Assembly of a Recombinant GABAAReceptor Subtype
Tretter, V., Ehya, N., Fuchs, K., & Sieghart, W. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02728.1997 · Cited by 484
Interaction at end-plate receptors between different choline derivatives
Castillo, J. D., & Katz, B. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0018 · Cited by 470
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
Amin, J., & Weiss, D. S. (1993) · Nature · doi:10.1038/366565a0 · Cited by 426
Self-citation
Cited by
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
The cellular, molecular and ionic basis of GABAA receptor signalling
Farrant, M., & Kaila, K. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)60005-8 · Cited by 368
Hooked on benzodiazepines: GABAA receptor subtypes and addiction
Tan, K. R., Rudolph, U., & Lüscher, C. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.004 · Cited by 365
GABAA receptor: Positive and negative allosteric modulators
Olsen, R. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.036 · Cited by 354
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“It enhances the effect of GABA at the GABA-A receptor, allowing it to exert a more significant effect [2].”
BackgroundWilliams, D. K., Wang, J., & Papke, R. L. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.001 · Cited by 246
Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond
Licata, S. C., & Rowlett, J. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.001 · Cited by 197
To Approach or Avoid: An Introductory Overview of the Study of Anxiety Using Rodent Assays
La-Vu, M., Tobias, B. C., Schuette, P. J., & Adhikari, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00145 · Cited by 182
McCarthy, M. M., Brown, E. N., & Kopell, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3536-08.2008 · Cited by 166
“The benzodiazepine drugs act on GABAA receptors and enhance the GABA response (Campo-Soria et al., 2006), and the inhalation anesthetics also potentiate GABAA receptor-mediated inhibition (Campagna et al., 2003).”
BackgroundHeterocyclic N-Oxides - An Emerging Class of Therapeutic Agents
Mfuh, A. M., & Larionov, O. V. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150619104007 · Cited by 158
Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration
Maier, J. A. M., Locatelli, L., Fedele, G., Cazzaniga, A., & Mazur, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010223 · Cited by 151
Direct Structural Insights into GABAA Receptor Pharmacology
Kim, J. J., & Hibbs, R. E. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.01.011 · Cited by 150
Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective
Goldschen-Ohm, M. P. (2022) · Biomolecules · doi:10.3390/biom12121784 · Cited by 146
The dual‐gate model for pentameric ligand‐gated ion channels activation and desensitization
Gielen, M. C., & Corringer, P. (2018) · The Journal of Physiology · doi:10.1113/jp275100 · Cited by 143
Aroniadou‐Anderjaska, V., Apland, J. P., Figueiredo, T. H., Furtado, M. D. A., & Braga, M. F. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108298 · Cited by 139
A Unified Model of the GABAA Receptor Comprising Agonist and Benzodiazepine Binding Sites
Bergmann, R., Kongsbak, K., Sørensen, P. L., Sander, T., & Balle, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052323 · Cited by 132
Benzodiazepines Modulate GABAAReceptors by Regulating the Preactivation Step after GABA Binding
Gielen, M. C., Lumb, M. J., & Smart, T. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5663-11.2012 · Cited by 116
From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors
Wulff, P., Goetz, T., Leppä, E., Linden, A.-M., Renzi, M., Swinny, J. D., Vekovischeva, O. Y., Sieghart, W., Somogyi, P., Korpi, E. R., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1927 · Cited by 110
Number and Locations of Agonist Binding Sites Required to Activate Homomeric Cys-Loop Receptors
Rayes, D., Rosa, M. J. D., Sine, S. M., & Bouzat, C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0627-09.2009 · Cited by 111
Chiffre, A., Clérandeau, C., Dwoinikoff, C., Bihanic, F. L., Budzinski, H., Géret, F., & Cachot, J. (2014) · Environmental Science and Pollution Research · doi:10.1007/s11356-014-3477-4 · Cited by 87
Mechanisms of action of antiseizure drugs
Porter, R. J., Dhir, A., Macdonald, R. L., & Rogawski, M. A. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52899-5.00021-6 · Cited by 91
Kramer, P. F., Twedell, E. L., Shin, J. H., Zhang, R., & Khaliq, Z. M. (2020) · eLife · doi:10.7554/elife.55729 · Cited by 88
Melatonin as a Chronobiotic with Sleep-promoting Properties
Sanabria, F. C., Carmassi, C., Bruno, S., Bazzani, A., Carli, M., Scarselli, M., & Faraguna, U. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220217152617 · Cited by 82
Apland, J. P., Aroniadou‐Anderjaska, V., Figueiredo, T. H., Rossetti, F., Miller, S. L., & Braga, M. F. M. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217299 · Cited by 68
Hammer, H., Bader, B. M., Ehnert, C., Bundgaard, C., Bunch, L., Hoestgaard-Jensen, K., Schroeder, O. H.-U., Bastlund, J. F., Gramowski, A., & Jensen, A. A. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099291 · Cited by 74
Barberis, A., Petrini, E. M., & Mozrzymas, J. W. (2011) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2011.00006 · Cited by 71
Kumar, A., Mehan, S., Tiwari, A., Khan, Z., Gupta, G. D., Narula, A. S., & Samant, R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128321466240816075041 · Cited by 67
Aroniadou‐Anderjaska, V., Figueiredo, T. H., Apland, J. P., & Braga, M. F. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.017 · Cited by 63
Skike, C. E. V., Botta, P., Chin, V. S., Tokunaga, S., McDaniel, J. R., Venard, J., Diaz‐Granados, J. L., Valenzuela, C. F., & Matthews, D. B. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01303.x · Cited by 58
Distinct Structural Changes in the GABAA Receptor Elicited by Pentobarbital and GABA
Muroi, Y., Theusch, C. M., Czajkowski, C., & Jackson, M. B. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.09.037 · Cited by 55
α1β2δ, a silent GABAAreceptor: recruitment by tracazolate and neurosteroids
Zheleznova, N., Sedelnikova, A., & Weiss, D. S. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707665 · Cited by 55
Self-citationRegulation of GABAA receptors by prolonged exposure to endogenous and exogenous ligands
Gravielle, M. C. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.015 · Cited by 53
Saporito, M. S., Gruner, J. A., DiCamillo, A., Hinchliffe, R. M., Barker‐Haliski, M. L., & White, H. S. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252155 · Cited by 52
Mozrzymas, J. W., Wójtowicz, T., Piast, M., Lebida, K., Wyrembek, P., & Mercik, K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143602 · Cited by 53
Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats
Ugale, R. R., Sharma, A. N., Kokare, D. M., Hirani, K., Subhedar, N. K., & Chopde, C. T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.041 · Cited by 56
Morlock, E. V., & Czajkowski, C. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.069542 · Cited by 53
Kloda, J. H., & Czajkowski, C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028662 · Cited by 47
Birnir, B., & Korpi, E. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782341330 · Cited by 44
Nielsen, S. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_425 · Cited by 52
A novel graph mining approach to predict and evaluate food-drug interactions
Rahman, M. M., Vadrev, S. M., Magana-Mora, A., Levman, J. E. D., & Soufan, O. (2022) · Scientific Reports · doi:10.1038/s41598-022-05132-y · Cited by 46
Cornwell, A. C., Tisdale, A. A., Venkat, S., Maraszek, K. E., Alahmari, A. A., George, A. M., Attwood, K. M., George, M., Rempinski, D., Franco‐Barraza, J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0547 · Cited by 44
Goldschen-Ohm, M. P., Wagner, D. A., Petrou, S., & Jones, M. V. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058289 · Cited by 44
Oxytocin enhances the inhibitory effects of diazepam in the rat central medial amygdala
Viviani, D., Terrettaz, T., Magara, F., & Stoop, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.039 · Cited by 46
Anzini, M., Braile, C., Valenti, S., Cappelli, A., Vomero, S., Marinelli, L., Limongelli, V., Novellino, E., Betti, L., Giannaccini, G., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002944 · Cited by 47
Steinbach, J. H., & Akk, G. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113787 · Cited by 40
Membrane Potential Measurements of Isolated Neurons Using a Voltage-Sensitive Dye
Fairless, R., Beck, A., Kravchenko, M., Williams, S. K., Wissenbach, U., Diem, R., & Cavalié, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058260 · Cited by 42
Anti-anxiety Properties of Selected Medicinal Plants
Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S. A., Munir, N., Zainab, R., Heydari, M., Mosavat, S. H., Ребезов, М. Б., et al. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210122125131 · Cited by 40
da Cunha, R. S., Amorim, K. D. S., Gercina, A. C., de Oliveira, A. C. A., Menezes, L. D. S., Groppo, F. C., & Souza, L. M. A. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03468-1 · Cited by 36
Goldschen-Ohm, M. P., Haroldson, A., Jones, M. V., & Pearce, R. A. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201411183 · Cited by 35
Akk, G., Shin, D. J., Germann, A. L., & Steinbach, J. H. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.110569 · Cited by 34
Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity
Dixon, C. L., Harrison, N. L., Lynch, J. W., & Keramidas, A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13142 · Cited by 40
Awareness and current knowledge of epilepsy
Khan, A. U., Akram, M., Daniyal, M., Akhter, N., Riaz, M., Akhtar, N., Shariati, M. A., Anjum, F., Khan, S. G., Parveen, A., et al. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00494-1 · Cited by 36
Li, P., Eaton, M. M., Steinbach, J. H., & Akk, G. (2013) · Anesthesiology · doi:10.1097/aln.0b013e318289bcd3 · Cited by 34
Sancar, F., & Czajkowski, C. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.009 · Cited by 30
A study on synthesis of benzodiazepine scaffolds using biologically active chalcones as precursors
Bhathiwal, A. S., Bendi, A., & Tiwari, A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132649 · Cited by 30
Elucidating Pathway and Anesthetic Mechanism of Action of Clove Oil Nanoformulations in Fish
Kheawfu, K., Pikulkaew, S., Wellendorph, P., Jørgensen, L. V. G., Rades, T., Müllertz, A., & Okonogi, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050919 · Cited by 31
The Role of Phospholipase C in GABAergic Inhibition and Its Relevance to Epilepsy
Kim, H. Y., Suh, P., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063149 · Cited by 29
Weltzin, M. M., & Schulte, M. K. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223933 · Cited by 32
Benzodiazepines for prolonged seizures
Anderson, M. (2010) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2009.176321 · Cited by 33
Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy
Patel, S., Birnbaum, A. K., Cloyd, J. C., & Leppik, I. E. (2015) · CNS Drugs · doi:10.1007/s40263-015-0289-0 · Cited by 30
Apland, J. P., Aroniadou‐Anderjaska, V., Figueiredo, T. H., Furtado, M. D. A., & Braga, M. F. M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9907-1 · Cited by 27
The F-loop of the GABAA Receptor γ2 Subunit Contributes to Benzodiazepine Modulation
Padgett, C. L., & Lummis, S. C. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705699200 · Cited by 27
Sleep promoting and omics exploration on probiotics fermented Gastrodia elata Blume
Zhang, C.-Q., Zhang, X.-D., Wang, Y., Liu, Y., Zhang, Q., & Zhang, Q. (2024) · npj Science of Food · doi:10.1038/s41538-024-00277-8 · Cited by 26
Clinical practice: The treatment of acute convulsive seizures in children
Lagae, L. G. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1403-z · Cited by 30
Venkatachalan, S. P., & Czajkowski, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316836 · Cited by 26
Zinc Potentiates Neuronal Nicotinic Receptors by Increasing Burst Duration
Hsiao, B., Mihalak, K. B., Magleby, K. L., & Luetje, C. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01040.2007 · Cited by 31
Soliman, S. S., Mahmoud, A. M., Elghobashy, M. R., Zaazaa, H. E., & Sedik, G. A. (2023) · Talanta · doi:10.1016/j.talanta.2023.125238 · Cited by 25
Prager, E. M., Figueiredo, T. H., Long, R. P., Aroniadou‐Anderjaska, V., Apland, J. P., & Braga, M. F. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.014 · Cited by 26
Guerrini, G., Ciciani, G., Cambi, G., Bruni, F., Selleri, S., Melani, F., Montali, M., Martini, C., Ghelardini, C., Norcini, M., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.058 · Cited by 25
Estimating the efficiency of benzodiazepines on GABA A receptors comprising γ1 or γ2 subunits
Baburin, I., Khom, S., Timin, E., Hohaus, A., Sieghart, W., & Hering, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.271 · Cited by 25
Newman, E. L., Smith, K. S., Takahashi, A., Chu, A., Hwa, L. S., Chen, Y., DeBold, J. F., Rudolph, U., & Miczek, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4069-9 · Cited by 27
Perineuronal Nets Alterations Contribute to Stress-Induced Anxiety-Like Behavior
Li, X., Ren, D., Luo, B., Liu, Z., Li, N.-Y., Zhou, T. G., & Fei, E. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03596-1 · Cited by 21
Biological profiling of piperazinediones for the management of anxiety
Kumar, D., Gupta, S. K., Ganeshpurkar, A., Singh, R., Kumar, D., Das, N., Krishnamurthy, S., & Singh, S. K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.11.009 · Cited by 21
Effects of Serotonin on the Induction of Long-term Depression in the Rat Visual Cortex
Jang, H., Cho, K., Park, S., Kim, M.-J., Yoon, S. H., & Rhie, D. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.5.337 · Cited by 21
Niquet, J., Nguyen, D. A., Furtado, M. D. A., & Lumley, L. A. (2023) · Epilepsia Open · doi:10.1002/epi4.12713 · Cited by 20
Aldrin-Kirk, P., & Björklund, T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9065-8_4 · Cited by 24
Walia, V., Garg, C., & Garg, M. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.06.001 · Cited by 19
Context Dependent Benzodiazepine Modulation of GABAA Receptor Opening Frequency
Bianchi, M. T. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909467 · Cited by 21
Jatczak-Śliwa, M., Terejko, K., Brodzki, M., Michałowski, M. A., Czyzewska, M. M., Nowicka, J., Andrzejczak, A., Srinivasan, R., & Mozrzymas, J. W. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00237 · Cited by 18
A critical residue in the α1M2–M3 linker regulating mammalian GABAA receptor pore gating by diazepam
Nors, J. W., Gupta, S., & Goldschen-Ohm, M. P. (2021) · eLife · doi:10.7554/elife.64400 · Cited by 19
Tandem couture: Cys-loop receptor concatamer insights and caveats
Ericksen, S. S., & Boileau, A. J. (2007) · Molecular Neurobiology · doi:10.1007/bf02700627 · Cited by 22
B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor
Post-Munson, D. J., Pieschl, R. L., Molski, T. F. P., Graef, J. D., Hendricson, A. W., Knox, R. J., McDonald, I. M., Olson, R. E., Macor, J. E., Weed, M. R., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.037 · Cited by 19
Toxicogenomic differentiation of functional responses to fipronil and imidacloprid in Daphnia magna
Pfaff, J., Reinwald, H., Ayobahan, S. U., Alvincz, J., Göckener, B., Shomroni, O., Salinas, G., Düring, R., Schäfers, C., & Eilebrecht, S. (2021) · Aquatic Toxicology · doi:10.1016/j.aquatox.2021.105927 · Cited by 17
da Silva, J. B., Temponi, V. D. S., Fernandes, F. V., Alves, G. D. A. D., de Matos, D. M., Gasparetto, C. M., Ribeiro, A. D. D. C., Pinho, J. D. J. R. G. D., Alves, M. S., & de Sousa, O. V. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128993 · Cited by 17
Mechanism of Allosteric Modulation of the Cys-loop Receptors
Chang, Y., Huang, Y., & Whiteaker, P. (2010) · Pharmaceuticals · doi:10.3390/ph3082592 · Cited by 19
Self-citationIntranasal Delivery of Two Benzodiazepines, Midazolam and Diazepam, by a Microemulsion System
Botner, S., & Sintov, A. C. (2011) · Pharmacology & Pharmacy · doi:10.4236/pp.2011.23026 · Cited by 16
David, F., Ngoupaye, G. T., Ouafo, A. C., Njapdounke, S. J. K., Kenneth, Y. A., & Bum, E. N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00685 · Cited by 16
Influence of midazolam premedication on intraoperative EEG signatures in elderly patients
Windmann, V., Spies, C., Brown, E. N., Kishnan, D., Lichtner, G., & Koch, S. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.05.035 · Cited by 16
GABAA Receptor β2E155 Residue Located at the Agonist-Binding Site Is Involved in the Receptor Gating
Jatczak-Śliwa, M., Kisiel, M., Czyzewska, M. M., Brodzki, M., & Mozrzymas, J. W. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00002 · Cited by 18
Cazzaniga, A., Fedele, G., Castiglioni, S., & Maier, J. A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095133 · Cited by 16
Application of the Co-Agonist Concerted Transition Model to Analysis of GABAA Receptor Properties
Germann, A. L., Steinbach, J. H., & Akk, G. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181206092418 · Cited by 16
Mendis, G. D. C., Berecki, G., Morrisroe, E., Pachernegg, S., Li, M., Varney, M. A., Osborne, P. B., Reid, C. A., Halgamuge, S. K., & Petrou, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37138-w · Cited by 17
Dupre, M. L., Broyles, J. M., & Mihic, S. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.031 · Cited by 16
In search of negative allosteric modulators of biological targets
Groebe, D. R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.011 · Cited by 15
Pflanz, N. C., Daszkowski, A. W., Cornelison, G. L., Trudell, J. R., & Mihic, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002128 · Cited by 15
Furtado, M. D. A., Aroniadou‐Anderjaska, V., Figueiredo, T. H., Apland, J. P., & Braga, M. F. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14331 · Cited by 15
Hanson, S. M., & Czajkowski, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01073.x · Cited by 15
Papke, R. L., Peng, C., Kumar, A., & Stokes, C. A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.025 · Cited by 15
Walia, V., Garg, C., & Garg, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.007 · Cited by 14
Metadata
- Authors
- Campo‐Soria, C., Chang, Y., & Weiss, D. S.
- Affiliations
- Barrow Neurological Institute (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Weiss, David S
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-08
- Volume
- 148
- Issue
- 7
- Pages
- 984-990
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1751932
- OpenAlex
- W1559609624
- Cited by
- 212
- References
- 31
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 11 · 2020: 11 · 2019: 12 · 2018: 16 · 2017: 7 · 2016: 2 · 2015: 9 · 2014: 12 · 2013: 11 · 2012: 6
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, diazepam, DMCM, receptor modulation, GABA binding sites, receptor desensitization, ligand-gated ion channels, Xenopus oocyte expression, EC50
- MeSH terms
- Algorithms, Animals, Benzodiazepines, Carbolines, Diazepam, Dose-Response Relationship, Drug, Kinetics, Microelectrodes, Mutation, Oocytes, Receptors, GABA-A, Transcription, Genetic, Xenopus laevis, Mutagenesis, Site-Directed, RNA, Complementary, GABA Agonists, GABA Antagonists, GABA Modulators, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.